Call for Abstracts now open: 9th EuroQol Academy 2025 and 5th EuroQol Early Career Researcher Meeting 2025
Interested to participate in one of our annual meetings? The...
EQ-5D-Y-5L launched! A new EuroQol instrument providing children and adolescents with a wider range of options to describe their HRQoL
Launched as an approved EuroQol Group instrument today, the EQ-5D-Y-5L...
Our Monthly Scientific Selection: August Publications on EuroQol Instruments #8
[1-31 August 2024] Zhang G, Yang Z, Luo N, Wang...
October 14, 2024
Our Monthly Scientific Selection: September Publications on EuroQol Instruments #9
[1-30 September 2024]
- Addo R, Mulhern B, Norman R, Owusu R, Viney R, Nonvignon J. An EQ-5D-5L Value Set for Ghana Using an Adapted EuroQol Valuation Technology Protocol. Value Health Reg Issues. 2024 Sep 4.
- Engel L, Bailey C, Bogatyreva E, Batchelor F, Devlin N, Dow B, Gilbert AS, Mulhern B, Viney R, Peasgood T. Appropriateness of the EQ-HWB for Use in Residential Aged Care: A Proxy Perspective. Patient. 2024 Sep 5.
- Chua AP, Cheng LJ, Soh ZY, Chen LA, Luo N. Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis. Patient. 2024 Sep 7.
- Jonker MF. The impact of demographic change on value set validity and obsolescence. Qual Life Res. 2024 Sep 13.
- Scott ES, Lubetkin EI, Janssen MF, Yfantopolous JN, Bonsel GJ, Haagsma JA. The performance relationship between the EQ-5D-5L composite “Anxiety/Depression” dimension and anxiety and depression symptoms in a large, general population sample. Qual Life Res. 2024 Sep 13.
- Besser M, O’Sullivan SB, Bourke S, Longworth L, Barcelos GT, Oluboyede Y. Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study. J Patient Rep Outcomes. 2024 Sep 26.
- Lee-Yin Tan R, Ng ZM, Chen LA, Herdman M, Luo N. Cross-cultural adaptation and content validation of the Singapore English version of EQ-5D-Y: a qualitative study. Health Qual Life Outcomes. 2024 Sep 27.
- Szabó Á, Brodszky V, Rencz F. Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases. Eur J Health Econ. 2024 Sep 28.